Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System

Background: Real-world studies on the allergen specific immunotherapy (AIT), omalizumab, and dupilumab associated anaphylactic events are limited. We aimed to analyze the characteristics of drug associated anaphylaxis, and to compare the differences among different drugs. Methods: A disproportionali...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Sainan, Zhang, Pingping, Li, Lisha, Wang, Zixi, Cui, Le, Xu, Yingyang, Guan, Kai, Zhao, Bin, Chen, Zhuanggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569862/
https://www.ncbi.nlm.nih.gov/pubmed/34744748
http://dx.doi.org/10.3389/fphar.2021.767999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569862/
https://www.ncbi.nlm.nih.gov/pubmed/34744748
http://dx.doi.org/10.3389/fphar.2021.767999

Ejemplares similares